Global Drugs of Abuse Testing Market Report and Forecast 2024-2032

Global Drugs of Abuse Testing Market Outlook

The global drugs of abuse testing market size was valued at USD 6.64 billion in 2023. The major drivers of the market include the presence of prominent players, increasing prevalence of substance abuse, drug of abuse testing device companies, rising risk of drug dependence and substance use disorder, increasing incidence of opioid dependence, and technological advancements in drug screening/testing devices. The market is anticipated to grow at a CAGR of 7.1% during the forecast period 2024-2032 to reach a value of USD 12.31 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for Drugs of Abuse Testing

North America is anticipated to be the largest regional market primarily because of the presence of prominent players undertaking extensive expansion strategies. Its dominant share could also be attributed to the rising prevalence of substance abuse in the region and government initiatives to control it. The rising rate of substance use disorder owin to the COVID-19 pandemic is anticipated to augment the demand for drug of abuse testing services in the region. However, nationwide lockdowns due to COVID-19 are expected to reduce the demand for workplace drug testing services, thus leading to sluggish market growth. Regional growth can also be attributed to the strong presence of drug of abuse testing device companies, along with progressing regulatory framework. Various federal government sources, including regulations, guidance, and public notices, provide essential information on drug substances favouring public health.

Further, the growing government initiative to trace the use of drugs among the population is facilitating the adoption of drug of abuse testing. For instance, the United States government implemented the Patients and Communities Act to counter the problem of drug abuse.

Market Segmentations

Drugs of abuse are compounds that have a specific effect on the user's brain, primarily in the reward circuitry. Drugs of abuse, in general, create either positive or negative feelings within seconds to minutes of administration. Drug tests, in general, do not detect drug use. On the other hand, drug tests identify specific drug classes or substances in biological matrices represented in specific test panels.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on products and services, the drugs of abuse market can be divided into:

• Analysers
• Consumables
• Rapid Testing Devices
• Laboratory Services

By sample type, the market is divided into:

• Urine
• Oral Fluid (Saliva)
• Hair
• Breath
• Others

The end-users of the market are:

• Workplaces and Schools
• Criminal Justice Systems and Law Enforcement Agencies
• Research Laboratories
• Hospitals

The regional markets for the drugs of abuse testing market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increase in the Consumption of Illicit Drugs Augmenting the Market Growth

The rapid rise in the consumption of alcohol and illicit drugs has led to the market's high growth. Opiates, cocaine, cannabinoids, lysergic acid diethylamide (LSD), barbiturates, amphetamines, alcohol, diazepam, and ketamine are frequently misused for their mind-altering properties, non-therapeutic and medicinal uses, and other goals, such as weight loss and sports performance enhancement. One of the leading causes driving the demand for drug of abuse testing worldwide is the risk of drug dependence and substance use disorder. As the incidence of opioid dependence continues to rise, healthcare professionals and other medical institutes are running regular tests and screening of the elderly to diagnose signs of drug abuse at an early stage. This is expected to spur the demand for drugs of abuse testing tools and equipment in hospitals and diagnostics. Various government programmes are designed to monitor and combat substance usage. Thus, the rise in government initiatives to monitor and combat substance abuse is also significantly driving the market. In addition, prominent companies provide automated testing and analysis for illicit drugs. These companies are also giving at-home kits for rapid drug misuse tests, which is fuelling the expansion of the global market.

Key Players in the Global Drugs of Abuse Testing Market

The report gives a detailed analysis of the following key players in the global drugs of abuse testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Lifeloc Technologies, Inc
• Abbott Laboratories.
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.
• Quest Diagnostics
• Premier Biotech, Inc.
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report